Identification of restriction endonucleases sensitive to 5-cytosine methylation at non-CpG sites, including expanded (CAG)n/(CTG)n repeats

Epigenetics

Volumn 6, Issue 4, 2011, Pages 417-421

  Castel, Arturo López ^a   Nakamori, Masayuki ^b   Thornton, Charles A ^b   Pearson, Christopher E ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

5 methylcytosine; ApeKI; BbvI; CpG methylation; EcoP151; Fnu4HI; MwoI and TseI; Non CpG methylation; Trinucleotide repeats

Indexed keywords

5 METHYLCYTOSINE; RESTRICTION ENDONUCLEASE; RESTRICTION ENDONUCLEASE APEKI; RESTRICTION ENDONUCLEASE BBVI; RESTRICTION ENDONUCLEASE ECOP15I; RESTRICTION ENDONUCLEASE FNU4HI; RESTRICTION ENDONUCLEASE MWOI; RESTRICTION ENDONUCLEASE TSEI; UNCLASSIFIED DRUG; DNA;

ARTICLE; CAG REPEAT; CPG ISLAND; DIFFERENTIATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; HUMAN; IN VITRO STUDY; METHYLATION; MOLECULAR RECOGNITION; PLASMID; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; CHEMISTRY; DNA METHYLATION; GENETICS; TRINUCLEOTIDE REPEAT;

5-METHYLCYTOSINE; DNA; DNA METHYLATION; DNA RESTRICTION ENZYMES; PLASMIDS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 80052070426     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.4.14953     Document Type: Article

References (37)

1. Gopalakrishnan S, Van Emburgh BO, Robertson KD. DNA methylation in development and human disease. Mutat Res 2008; 647:30-8.
2. Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005; 6:729-42.
3. López Castel A, Cleary JD, Pearson CE. Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol 2010; 11:165-70.
4. Winnepenninckx B, Debacker K, Ramsay J, Smeets D, Smits A, Fitz-Patrick DR, et al. CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13. Am J Hum Genet 2007; 80:221-31.
5. Dion V, Wilson JH. Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet 2009; 25:288-97.
6. Kumari D, Usdin K. Chromatin remodeling in the noncoding repeat expansion disease. J Biol Chem 2009; 284:7413-7.
7. Park CW, Chen Z, Kren BT, Steer CJ. Double-stranded siRNA targeted to the huntingtin gene does not induce DNA methylation. Biochem Biophys Res Commun 2004; 323:275-80.
8. Theilmann JL, Robbins CA, Hayden MR. Methylation at the D4S95 locus and predictive testing. Am J Hum Genet 1989; 45:477-9.
9. Pritchard CA, Cox DR, Myers RM. Methylation at the Huntington disease-linked D4S95 locus. Am J Hum Genet 1989; 45:335-6.
10. Reik W, Maher ER, Morrison PJ, Harding AE, Simpson SA. Age at onset in Huntington's disease and methylation at D4S95. J Med Genet 1993; 30:185-8.
11. López Castel A, Nakamori M, Tomé S, Chitayat D, Gourdon G, Thornton CA, et al. Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. Hum Mol Genet 2010; 20:1-15.
12. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-22.
13. Grandjean V, Yaman R, Cuzin F, Rassoulzadegan M. Inheritance of an epigenetic mark: the CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation. PLoS One 2007; 2:1136.
14. Burden AF, Manley NC, Clark AD, Gartler SM, Laird CD, Hansen RS. Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J Biol Chem 2005; 280:14413-9.
15. Imamura T, Kerjean A, Heams T, Kupiec JJ, Thenevin C, Pàldi A. Dynamic CpG and non-CpG methylation of the Peg1/Mest gene in the mouse oocyte and preimplantation embryo. J Biol Chem 2005; 280:20171-5.
16. Inoue S, Oishi M. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11). Gene 2005; 348:123-34.
17. Dodge JE, Ramsahoye BH, Wo ZG, Okano M, Li E. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 2002; 289:41-8.
18. White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN gamma promoter at CpG and non-CpG sites underlie differences in IFN gamma gene expression between human neonatal and adult CD45RO-T cells. J Immunol 2002; 168:2820-7.
19. Haines TR, Rodenhiser DI, Ainsworth PJ. Allele-specific non-CpG methylation of the Nf1 gene during early mouse development. Dev Biol 2001; 240:585-98.
20. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA 2000; 97:5237-42.
21. Woodcock DM, Crowther PJ, Diver WP. The majority of methylated deoxycytidines in human DNA are not in the CpG dinucleotide. Biochem Biophys Res Commun 1987; 145:888-94.
22. Aoki A, Suetake I, Miyagawa J, Fujio T, Chijiwa T, Sasaki H, et al. Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases. Nucleic Acids Res 2001; 29:3506-12.
23. Gowher H, Jeltsch A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. J Mol Biol 2001; 309:1201-8.
24. Lee J, Jang SJ, Benoit N, Hoque MO, Califano JA, Trink B, et al. Presence of 5-methylcytosine in CpNpG trinucleotides in the human genome. Genomics 2010; 96:67-72.
25. Roberts RJ, Vincze T, Posfai J, Macelis D. REBASE-a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Res 2010; 38:234-6.
26. Ramsahoye BH, Burnett AK, Taylor C. Restriction endonuclease isoschizomers ItaI, BsoFI and Fsp4HI are characterized by differences in their sensitivities to CpG methylation. Nucleic Acids Res 1997; 25:3196-8.
27. Hansen RS, Gartler SM, Scott CR, Chen SH, Laird CD. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum Mol Genet 1992; 1:571-8.
28. Pietrobono R, Pomponi MG, Tabolacci E, Oostra B, Chiurazzi P, Neri G. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res 2002; 30:3278-85.
29. Xu M, Kladde MP, Van Etten JL, Simpson RT. Cloning, characterization and expression of the gene coding for a cytosine-5-DNA methyltransferase recognizing GpC. Nucleic Acids Res 1998; 26:3961-6.
30. Osborne RJ, Thornton CA. Cell-free cloning of highly expanded CTG repeats by amplification of dimerized expanded repeats. Nucleic Acids Res 2008; 36:24.
31. Mann MB, Smith HO. Specificity of HpaII and HaeIII DNA methylases. Nucleic Acids Res 1977; 4:4211-21.
32. Backman K. A cautionary note on the use of certain restriction endonucleases with methylated substrates. Gene 1980; 11:169-71.
33. Fuso A, Ferraguti G, Grandoni F, Ruggeri R, Scarpa S, Strom R, et al. Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5′-flanking region: a priming effect on the spreading of active demethylation. Cell Cycle 2010; 9:3965-76.
34. Möncke-Buchner E, Reich S, Mücke M, Reuter M, Messer W, Wanker EE, et al. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage. Nucleic Acids Res 2002; 30:83.
35. Greene E, Mahishi L, Entezam A, Kumari D, Usdin K. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res 2007; 35:3383-90.
36. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2006; 2:551-8.
37. Al-Mahdawi S, Pinto RM, Ismail O, Varshney D, Lymperi S, Sandi C, et al. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum Mol Genet 2008; 17:735-46.